Why the study?
It is unclear whether renal transplantation is safe, whether it has different impacts on ischemic versus nonischemic reduced LVEF, and if myocardial revascularization influences prognosis.
Does renal transplantation improve LVEF and survival in dialysis patients with ischemic and nonischemic cardiomyopathy?
Does renal transplantation improve LVEF and survival in dialysis patients with ischemic and nonischemic cardiomyopathy?
Renal transplantation is safe and associated with substantial LVEF improvement in patients with reduced LVEF, suggesting reduced LVEF should not preclude transplantation.
May warrant reevaluating RT exclusion criteria in reduced LVEF; leaves open need for randomized confirmation.
BACKGROUND: Transplant centers exclude patients from the waiting list with reduced left ventricular ejection fraction (LVEF). It is unclear whether renal transplantation (RT) is safe, will have different impacts on patients with ischemic/nonischemic reduced LVEF, and whether myocardial revascularization will influence prognosis. METHODS: Four hundred and sixty RT patients assessed for coronary artery disease (CAD) and with LVEF determined before and after RT were divided into four groups (Group 1: No CAD and normal LVEF [reference]; Group 2: CAD and normal LVEF; Group 3: No CAD and reduced LVEF [nonischemic cardiomyopathy]; Group 4: CAD and reduced LVEF [ischemic cardiomyopathy]) and followed until death. RESULTS: RT was associated with increased LVEF in patients with cardiomyopathy. Patients with ischemic cardiomyopathy had a reduced survival rate; coronary intervention and medical treatment had comparable effects on outcomes. However, LVEF or CAD did not influence outcomes. CONCLUSIONS: RT can be performed safely in patients with ischemic and nonischemic reduced LVEF and is associated with substantial improvement in LVEF. Although the long-term outcomes were poorer in patients with ischemic disease, LVEF and CAD were not independent predictors of events or death after adjustments. Therefore, reduced LVEF, even in patients with CAD, should not hamper the indication for RT.
No takes yet. Share an insight, caveat, or question.
Lima et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: